About this trial
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer.
The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies....
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female, adults or children >= 6 months+.
Patients with known or suspected thyroid nodules and/or thyroid cancer.
At risk family members of patients who have a genetic susceptibility to developing thyroid cancer.
Disqualifiers
None
Trial population
Only those with thyroid nodules and/or thyroid cancer will be allowed to enroll.
Trial design
Case-only
Prospective
Treatments tested in this trial
68-Gallium Dotatate
DrugFor evaluation risk/benefit evaluation
Treatment groups
Trial outcomes
Primary outcomes
Evaluation of thyroid cancer
Blood draws, CT and other scans, physical exams, surgery (if applicable), thyroid biopsy (if applicable).
Evaluation of thyroid disorders
blood draws, CT and other scans, physical exam.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.